Mesoblast (MESO) Return on Sales (QoQ) (2016 - 2023)

Mesoblast (MESO) Return on Sales (QoQ) (2016 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Mesoblast 19.81 Bn 19.68 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2023 17.00
Mar 31, 2023 -3.00
Dec 31, 2022 5.00
Sep 30, 2022 55.00
Jun 30, 2022 -58.00
Mar 31, 2022 3.00
Dec 31, 2021 -2.00
Sep 30, 2021 20.00
Jun 30, 2021 2.00
Mar 31, 2021 -2.00
Dec 31, 2020 7.00
Sep 30, 2020 -18.00
Jun 30, 2020 6.00
Mar 31, 2020 5.00
Dec 31, 2019 -16.00
Sep 30, 2019 14.00
Jun 30, 2019 13.00
Mar 31, 2019 -4.00
Dec 31, 2018 -39.00
Sep 30, 2018 31.00